nodes	percent_of_prediction	percent_of_DWPC	metapath
Isopropamide—Loperamide—Toremifene—breast cancer	0.0873	0.091	CrCrCtD
Isopropamide—Doxylamine—Toremifene—breast cancer	0.0754	0.0786	CrCrCtD
Isopropamide—Dextropropoxyphene—Toremifene—breast cancer	0.0716	0.0747	CrCrCtD
Isopropamide—Phenoxybenzamine—Toremifene—breast cancer	0.0716	0.0747	CrCrCtD
Isopropamide—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0548	0.0571	CrCrCtD
Isopropamide—Loperamide—Tamoxifen—breast cancer	0.0548	0.0571	CrCrCtD
Isopropamide—Methadyl Acetate—Tamoxifen—breast cancer	0.0548	0.0571	CrCrCtD
Isopropamide—Clofedanol—Toremifene—breast cancer	0.0518	0.054	CrCrCtD
Isopropamide—Benzphetamine—Toremifene—breast cancer	0.0501	0.0522	CrCrCtD
Isopropamide—Doxylamine—Tamoxifen—breast cancer	0.0474	0.0494	CrCrCtD
Isopropamide—Benzyl Benzoate—Toremifene—breast cancer	0.0464	0.0484	CrCrCtD
Isopropamide—Dextropropoxyphene—Tamoxifen—breast cancer	0.045	0.0469	CrCrCtD
Isopropamide—Phenoxybenzamine—Tamoxifen—breast cancer	0.045	0.0469	CrCrCtD
Isopropamide—Diphenhydramine—Toremifene—breast cancer	0.0445	0.0464	CrCrCtD
Isopropamide—Methadone—Tamoxifen—breast cancer	0.0376	0.0392	CrCrCtD
Isopropamide—Clofedanol—Tamoxifen—breast cancer	0.0325	0.0339	CrCrCtD
Isopropamide—Benzphetamine—Tamoxifen—breast cancer	0.0315	0.0328	CrCrCtD
Isopropamide—Benzyl Benzoate—Tamoxifen—breast cancer	0.0292	0.0304	CrCrCtD
Isopropamide—Diphenhydramine—Tamoxifen—breast cancer	0.0279	0.0291	CrCrCtD
Isopropamide—Levomethadyl Acetate—CYP19A1—breast cancer	0.000282	0.114	CrCbGaD
Isopropamide—Darifenacin—CYP2D6—breast cancer	0.000205	0.083	CrCbGaD
Isopropamide—Darifenacin—CYP3A4—breast cancer	0.000176	0.0712	CrCbGaD
Isopropamide—Methadone—CYP19A1—breast cancer	0.000165	0.0668	CrCbGaD
Isopropamide—Disopyramide—CYP3A4—breast cancer	0.000163	0.0656	CrCbGaD
Isopropamide—Diphenhydramine—PTGS1—breast cancer	0.000138	0.0557	CrCbGaD
Isopropamide—Dextropropoxyphene—CYP2D6—breast cancer	0.000133	0.0539	CrCbGaD
Isopropamide—Levomethadyl Acetate—CYP3A4—breast cancer	0.000132	0.0535	CrCbGaD
Isopropamide—Loperamide—CYP2D6—breast cancer	0.000127	0.0514	CrCbGaD
Isopropamide—Modafinil—CYP3A4—breast cancer	0.000116	0.0468	CrCbGaD
Isopropamide—Dextropropoxyphene—CYP3A4—breast cancer	0.000115	0.0463	CrCbGaD
Isopropamide—Loperamide—CYP3A4—breast cancer	0.000109	0.0441	CrCbGaD
Isopropamide—Benzphetamine—CYP3A4—breast cancer	0.0001	0.0406	CrCbGaD
Isopropamide—Phenoxybenzamine—CYP3A4—breast cancer	9.6e-05	0.0388	CrCbGaD
Isopropamide—Diphenhydramine—CYP2D6—breast cancer	9.38e-05	0.0379	CrCbGaD
Isopropamide—Loperamide—ABCB1—breast cancer	9.08e-05	0.0367	CrCbGaD
Isopropamide—Methadone—CYP2D6—breast cancer	9.06e-05	0.0366	CrCbGaD
Isopropamide—Methadone—CYP3A4—breast cancer	7.77e-05	0.0314	CrCbGaD
Isopropamide—Methadone—ABCB1—breast cancer	6.47e-05	0.0261	CrCbGaD
Isopropamide—CHRM3—Signaling Pathways—AGTR1—breast cancer	1.02e-05	0.000266	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—STK11—breast cancer	1.01e-05	0.000263	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ADAM10—breast cancer	1.01e-05	0.000263	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—STK11—breast cancer	1.01e-05	0.000262	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ADAM10—breast cancer	1.01e-05	0.000262	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—ESR1—breast cancer	1e-05	0.00026	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PLG—breast cancer	9.99e-06	0.00026	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PLG—breast cancer	9.95e-06	0.000259	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—FN1—breast cancer	9.88e-06	0.000257	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—AKT2—breast cancer	9.88e-06	0.000257	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—AKT2—breast cancer	9.84e-06	0.000256	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—FGF10—breast cancer	9.82e-06	0.000256	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—GPX1—breast cancer	9.8e-06	0.000255	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—FGF10—breast cancer	9.79e-06	0.000255	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—NFKBIA—breast cancer	9.76e-06	0.000254	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—CYP1A1—breast cancer	9.7e-06	0.000253	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—NOTCH1—breast cancer	9.67e-06	0.000252	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—ERCC2—breast cancer	9.62e-06	0.000251	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—PIK3CD—breast cancer	9.49e-06	0.000247	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PDGFA—breast cancer	9.48e-06	0.000247	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—PIK3CD—breast cancer	9.46e-06	0.000246	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—KIT—breast cancer	9.46e-06	0.000246	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—APC—breast cancer	9.46e-06	0.000246	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—PIK3CG—breast cancer	9.46e-06	0.000246	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PDGFA—breast cancer	9.45e-06	0.000246	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—EGF—breast cancer	9.35e-06	0.000243	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—TGFBR2—breast cancer	9.34e-06	0.000243	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—TGFBR2—breast cancer	9.31e-06	0.000242	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ITPR1—breast cancer	9.19e-06	0.000239	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ITPR1—breast cancer	9.17e-06	0.000239	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ERBB4—breast cancer	9.13e-06	0.000238	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MMP3—breast cancer	9.13e-06	0.000238	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—STAT5A—breast cancer	9.13e-06	0.000238	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—PIK3CB—breast cancer	9.11e-06	0.000237	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MMP3—breast cancer	9.1e-06	0.000237	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—STAT5A—breast cancer	9.1e-06	0.000237	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ERBB4—breast cancer	9.1e-06	0.000237	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—PIK3CB—breast cancer	9.08e-06	0.000236	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—MAPK3—breast cancer	9.06e-06	0.000236	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—MTHFR—breast cancer	9.05e-06	0.000235	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—BRAF—breast cancer	8.89e-06	0.000231	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—SMAD4—breast cancer	8.85e-06	0.00023	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—SMAD4—breast cancer	8.82e-06	0.00023	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—IGF1R—breast cancer	8.79e-06	0.000229	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—IGF1R—breast cancer	8.76e-06	0.000228	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	8.75e-06	0.000228	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	8.72e-06	0.000227	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—IGF1—breast cancer	8.66e-06	0.000225	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—AKT2—breast cancer	8.65e-06	0.000225	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HES1—breast cancer	8.64e-06	0.000225	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—EGFR—breast cancer	8.62e-06	0.000224	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HES1—breast cancer	8.61e-06	0.000224	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—NCOR1—breast cancer	8.59e-06	0.000224	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	8.59e-06	0.000224	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—NCOR1—breast cancer	8.56e-06	0.000223	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	8.56e-06	0.000223	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CSF2—breast cancer	8.49e-06	0.000221	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—FGF1—breast cancer	8.49e-06	0.000221	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—RAF1—breast cancer	8.47e-06	0.00022	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CSF2—breast cancer	8.46e-06	0.00022	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—FGF1—breast cancer	8.46e-06	0.00022	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—RAF1—breast cancer	8.44e-06	0.00022	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—NRG1—breast cancer	8.43e-06	0.000219	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—NRG1—breast cancer	8.4e-06	0.000219	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—H2AFX—breast cancer	8.37e-06	0.000218	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—IL2—breast cancer	8.36e-06	0.000218	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—CAV1—breast cancer	8.34e-06	0.000217	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—H2AFX—breast cancer	8.34e-06	0.000217	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—IL2—breast cancer	8.34e-06	0.000217	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—PIK3CD—breast cancer	8.31e-06	0.000216	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—E2F1—breast cancer	8.31e-06	0.000216	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—E2F1—breast cancer	8.28e-06	0.000216	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	8.27e-06	0.000215	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	8.24e-06	0.000215	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—PIK3CA—breast cancer	8.23e-06	0.000214	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—SERPINE1—breast cancer	8.22e-06	0.000214	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—KRAS—breast cancer	8.14e-06	0.000212	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—SPP1—breast cancer	7.98e-06	0.000208	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—SPP1—breast cancer	7.96e-06	0.000207	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—CXCL8—breast cancer	7.95e-06	0.000207	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—CXCL8—breast cancer	7.92e-06	0.000206	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ERBB3—breast cancer	7.9e-06	0.000206	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—FGFR2—breast cancer	7.88e-06	0.000205	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ERBB3—breast cancer	7.87e-06	0.000205	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—FGFR2—breast cancer	7.86e-06	0.000205	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—NOS3—breast cancer	7.85e-06	0.000204	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—PIK3CG—breast cancer	7.6e-06	0.000198	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—IL2—breast cancer	7.6e-06	0.000198	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—IL2—breast cancer	7.57e-06	0.000197	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—TERT—breast cancer	7.57e-06	0.000197	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—TERT—breast cancer	7.54e-06	0.000196	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—PIK3CA—breast cancer	7.48e-06	0.000195	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—MDM2—breast cancer	7.45e-06	0.000194	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—RAF1—breast cancer	7.42e-06	0.000193	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—RELA—breast cancer	7.39e-06	0.000192	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—FGFR1—breast cancer	7.35e-06	0.000191	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—ERBB2—breast cancer	7.34e-06	0.000191	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—FGFR1—breast cancer	7.32e-06	0.000191	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—PIK3CB—breast cancer	7.25e-06	0.000189	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—MTOR—breast cancer	7.25e-06	0.000189	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HIF1A—breast cancer	7.24e-06	0.000188	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HIF1A—breast cancer	7.21e-06	0.000188	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—LEP—breast cancer	7.07e-06	0.000184	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—LEP—breast cancer	7.04e-06	0.000183	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CAV1—breast cancer	7e-06	0.000182	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CAV1—breast cancer	6.98e-06	0.000182	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—CXCL8—breast cancer	6.96e-06	0.000181	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—KDR—breast cancer	6.92e-06	0.00018	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—HRAS—breast cancer	6.92e-06	0.00018	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—KDR—breast cancer	6.9e-06	0.00018	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—CDKN1B—breast cancer	6.8e-06	0.000177	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ESR1—breast cancer	6.75e-06	0.000176	CbGpPWpGaD
Isopropamide—CHRM4—GPCR downstream signaling—AKT1—breast cancer	6.73e-06	0.000175	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ESR1—breast cancer	6.72e-06	0.000175	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—PIK3CD—breast cancer	6.68e-06	0.000174	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—CASP3—breast cancer	6.66e-06	0.000173	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—FN1—breast cancer	6.66e-06	0.000173	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—IL2—breast cancer	6.65e-06	0.000173	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—FN1—breast cancer	6.64e-06	0.000173	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—IL6—breast cancer	6.62e-06	0.000172	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—ALB—breast cancer	6.6e-06	0.000172	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—NFKBIA—breast cancer	6.58e-06	0.000171	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—NFKBIA—breast cancer	6.56e-06	0.000171	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—NOTCH1—breast cancer	6.52e-06	0.00017	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—NOTCH1—breast cancer	6.5e-06	0.000169	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—CCND1—breast cancer	6.49e-06	0.000169	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—JUN—breast cancer	6.47e-06	0.000168	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—CTNNB1—breast cancer	6.42e-06	0.000167	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PIK3CG—breast cancer	6.38e-06	0.000166	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—APC—breast cancer	6.38e-06	0.000166	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—KIT—breast cancer	6.38e-06	0.000166	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—APC—breast cancer	6.36e-06	0.000165	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PIK3CG—breast cancer	6.36e-06	0.000165	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—KIT—breast cancer	6.36e-06	0.000165	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—NOS3—breast cancer	6.31e-06	0.000164	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—EGF—breast cancer	6.3e-06	0.000164	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—MMP9—breast cancer	6.3e-06	0.000164	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—EGF—breast cancer	6.28e-06	0.000164	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—CDKN1A—breast cancer	6.28e-06	0.000163	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—PTEN—breast cancer	6.26e-06	0.000163	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—MAPK8—breast cancer	6.13e-06	0.000159	CbGpPWpGaD
Isopropamide—CHRM4—Signaling by GPCR—AKT1—breast cancer	6.11e-06	0.000159	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—MAPK3—breast cancer	6.11e-06	0.000159	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—MAPK3—breast cancer	6.09e-06	0.000158	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—BRAF—breast cancer	5.99e-06	0.000156	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—BRAF—breast cancer	5.97e-06	0.000156	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—IGF1—breast cancer	5.84e-06	0.000152	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—AKT2—breast cancer	5.83e-06	0.000152	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—PIK3CB—breast cancer	5.82e-06	0.000152	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—IGF1—breast cancer	5.82e-06	0.000151	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—AKT2—breast cancer	5.82e-06	0.000151	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—EGFR—breast cancer	5.81e-06	0.000151	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—SRC—breast cancer	5.81e-06	0.000151	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—EGFR—breast cancer	5.79e-06	0.000151	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—PTGS2—breast cancer	5.77e-06	0.00015	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—VEGFA—breast cancer	5.66e-06	0.000147	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PIK3CD—breast cancer	5.61e-06	0.000146	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—STAT3—breast cancer	5.6e-06	0.000146	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PIK3CD—breast cancer	5.59e-06	0.000145	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	5.55e-06	0.000145	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—SERPINE1—breast cancer	5.54e-06	0.000144	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	5.53e-06	0.000144	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—SERPINE1—breast cancer	5.53e-06	0.000144	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—KRAS—breast cancer	5.49e-06	0.000143	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—KRAS—breast cancer	5.47e-06	0.000142	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—MAPK3—breast cancer	5.35e-06	0.000139	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—NOS3—breast cancer	5.29e-06	0.000138	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—NOS3—breast cancer	5.28e-06	0.000137	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—MYC—breast cancer	5.2e-06	0.000135	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—TGFB1—breast cancer	5.19e-06	0.000135	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—EGFR—breast cancer	5.09e-06	0.000132	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	5.04e-06	0.000131	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—PTEN—breast cancer	5.03e-06	0.000131	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	5.03e-06	0.000131	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MDM2—breast cancer	5.02e-06	0.000131	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MDM2—breast cancer	5.01e-06	0.00013	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—RAF1—breast cancer	5e-06	0.00013	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—RAF1—breast cancer	4.99e-06	0.00013	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—RELA—breast cancer	4.98e-06	0.00013	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—RELA—breast cancer	4.97e-06	0.000129	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—ERBB2—breast cancer	4.95e-06	0.000129	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—ERBB2—breast cancer	4.94e-06	0.000128	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PIK3CB—breast cancer	4.89e-06	0.000127	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MTOR—breast cancer	4.89e-06	0.000127	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MTOR—breast cancer	4.87e-06	0.000127	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PIK3CB—breast cancer	4.87e-06	0.000127	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—KRAS—breast cancer	4.81e-06	0.000125	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CXCL8—breast cancer	4.7e-06	0.000122	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CXCL8—breast cancer	4.68e-06	0.000122	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—HRAS—breast cancer	4.66e-06	0.000121	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—HRAS—breast cancer	4.65e-06	0.000121	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CDKN1B—breast cancer	4.59e-06	0.000119	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CDKN1B—breast cancer	4.57e-06	0.000119	CbGpPWpGaD
Isopropamide—CHRM1—GPCR downstream signaling—AKT1—breast cancer	4.54e-06	0.000118	CbGpPWpGaD
Isopropamide—CHRM3—GPCR downstream signaling—AKT1—breast cancer	4.52e-06	0.000118	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CASP3—breast cancer	4.49e-06	0.000117	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—IL2—breast cancer	4.49e-06	0.000117	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CASP3—breast cancer	4.48e-06	0.000117	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—IL2—breast cancer	4.47e-06	0.000116	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—IL6—breast cancer	4.46e-06	0.000116	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—IL6—breast cancer	4.45e-06	0.000116	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—PIK3CA—breast cancer	4.42e-06	0.000115	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CCND1—breast cancer	4.37e-06	0.000114	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—JUN—breast cancer	4.36e-06	0.000114	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CCND1—breast cancer	4.36e-06	0.000113	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—JUN—breast cancer	4.35e-06	0.000113	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CTNNB1—breast cancer	4.33e-06	0.000113	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CTNNB1—breast cancer	4.32e-06	0.000112	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—TP53—breast cancer	4.27e-06	0.000111	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MMP9—breast cancer	4.25e-06	0.000111	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MMP9—breast cancer	4.23e-06	0.00011	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—CDKN1A—breast cancer	4.23e-06	0.00011	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PTEN—breast cancer	4.22e-06	0.00011	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—CDKN1A—breast cancer	4.22e-06	0.00011	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PTEN—breast cancer	4.21e-06	0.00011	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MAPK8—breast cancer	4.13e-06	0.000108	CbGpPWpGaD
Isopropamide—CHRM1—Signaling by GPCR—AKT1—breast cancer	4.12e-06	0.000107	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MAPK8—breast cancer	4.12e-06	0.000107	CbGpPWpGaD
Isopropamide—CHRM3—Signaling by GPCR—AKT1—breast cancer	4.11e-06	0.000107	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—HRAS—breast cancer	4.09e-06	0.000106	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—SRC—breast cancer	3.92e-06	0.000102	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—IL6—breast cancer	3.91e-06	0.000102	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—SRC—breast cancer	3.9e-06	0.000102	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—VEGFA—breast cancer	3.81e-06	9.93e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—VEGFA—breast cancer	3.8e-06	9.89e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—STAT3—breast cancer	3.78e-06	9.83e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—STAT3—breast cancer	3.76e-06	9.8e-05	CbGpPWpGaD
Isopropamide—CHRM4—Signaling Pathways—AKT1—breast cancer	3.61e-06	9.39e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MAPK3—breast cancer	3.61e-06	9.39e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MAPK3—breast cancer	3.6e-06	9.36e-05	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—PIK3CA—breast cancer	3.55e-06	9.24e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—MYC—breast cancer	3.51e-06	9.13e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—TGFB1—breast cancer	3.5e-06	9.11e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—MYC—breast cancer	3.5e-06	9.1e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—TGFB1—breast cancer	3.49e-06	9.08e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—EGFR—breast cancer	3.43e-06	8.93e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—EGFR—breast cancer	3.42e-06	8.9e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—KRAS—breast cancer	3.24e-06	8.44e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—KRAS—breast cancer	3.23e-06	8.41e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.98e-06	7.75e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—PIK3CA—breast cancer	2.97e-06	7.73e-05	CbGpPWpGaD
Isopropamide—CHRM3—Metabolism—AKT1—breast cancer	2.9e-06	7.55e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—TP53—breast cancer	2.88e-06	7.5e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—TP53—breast cancer	2.87e-06	7.48e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—HRAS—breast cancer	2.76e-06	7.17e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—HRAS—breast cancer	2.75e-06	7.15e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—IL6—breast cancer	2.64e-06	6.86e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—IL6—breast cancer	2.63e-06	6.84e-05	CbGpPWpGaD
Isopropamide—CHRM1—Signaling Pathways—AKT1—breast cancer	2.43e-06	6.33e-05	CbGpPWpGaD
Isopropamide—CHRM3—Signaling Pathways—AKT1—breast cancer	2.43e-06	6.31e-05	CbGpPWpGaD
